 for cancer
staging. It is not intended or designed to inﬂuence or
dictate treatment method, especially since treatment
modalities continue to evolve. The primary purpose of
this classiﬁcation is to provide more precise description of
the disease burden to allow accurate outcomes assessments
and comparisons between similar groups of patients and
alternative therapies. In addition, going forward, an
updated risk factor/comorbidity index and a simpler
anatomic classiﬁcation system will